ES2239937T1 - Procedimiento para la recuperacion de compuestos de estanina a partir de un caldo de fermentacion. - Google Patents
Procedimiento para la recuperacion de compuestos de estanina a partir de un caldo de fermentacion.Info
- Publication number
- ES2239937T1 ES2239937T1 ES04010770T ES04010770T ES2239937T1 ES 2239937 T1 ES2239937 T1 ES 2239937T1 ES 04010770 T ES04010770 T ES 04010770T ES 04010770 T ES04010770 T ES 04010770T ES 2239937 T1 ES2239937 T1 ES 2239937T1
- Authority
- ES
- Spain
- Prior art keywords
- pravastatin
- salt
- pharmacologically acceptable
- acid
- impurities
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract 26
- 238000000855 fermentation Methods 0.000 title claims abstract 3
- 230000004151 fermentation Effects 0.000 title claims abstract 3
- 229910001369 Brass Inorganic materials 0.000 title 1
- 239000010951 brass Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000011084 recovery Methods 0.000 title 1
- TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 claims abstract 19
- 150000003839 salts Chemical class 0.000 claims abstract 16
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 claims abstract 15
- 229960002965 pravastatin Drugs 0.000 claims abstract 15
- 239000007864 aqueous solution Substances 0.000 claims abstract 4
- 229960001495 pravastatin sodium Drugs 0.000 claims abstract 4
- 239000002904 solvent Substances 0.000 claims abstract 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract 3
- 238000002955 isolation Methods 0.000 claims abstract 3
- 238000000746 purification Methods 0.000 claims abstract 3
- 239000012535 impurity Substances 0.000 claims 9
- 239000002253 acid Substances 0.000 claims 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000005907 alkyl ester group Chemical group 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- OQARDMYXSOFTLN-PZAWKZKUSA-N pravastatin lactone Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 OQARDMYXSOFTLN-PZAWKZKUSA-N 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Manufacturing & Machinery (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16805699P | 1999-11-30 | 1999-11-30 | |
| US168056P | 1999-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2239937T1 true ES2239937T1 (es) | 2005-10-16 |
Family
ID=22609918
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES04010770T Pending ES2239937T1 (es) | 1999-11-30 | 2000-11-28 | Procedimiento para la recuperacion de compuestos de estanina a partir de un caldo de fermentacion. |
| ES00980834T Expired - Lifetime ES2273737T3 (es) | 1999-11-30 | 2000-11-28 | Procedimiento para la recuperacion de compuestos de estatina de un caldo de fermentacion. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00980834T Expired - Lifetime ES2273737T3 (es) | 1999-11-30 | 2000-11-28 | Procedimiento para la recuperacion de compuestos de estatina de un caldo de fermentacion. |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US6444452B1 (https=) |
| EP (1) | EP1265604B1 (https=) |
| JP (5) | JP3881240B2 (https=) |
| KR (1) | KR20030026920A (https=) |
| CN (2) | CN1433305A (https=) |
| AT (2) | ATE342717T1 (https=) |
| AU (1) | AU1804601A (https=) |
| CA (1) | CA2393057C (https=) |
| CY (1) | CY1105925T1 (https=) |
| DE (3) | DE04010770T1 (https=) |
| DK (1) | DK1265604T3 (https=) |
| ES (2) | ES2239937T1 (https=) |
| HR (1) | HRP20020454A2 (https=) |
| HU (1) | HUP0204012A3 (https=) |
| MX (1) | MXPA02005283A (https=) |
| PL (1) | PL364918A1 (https=) |
| PT (1) | PT1265604E (https=) |
| RU (1) | RU2002114072A (https=) |
| SK (1) | SK7342002A3 (https=) |
| WO (1) | WO2001039768A1 (https=) |
| YU (1) | YU39102A (https=) |
| ZA (1) | ZA200203912B (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7141602B2 (en) * | 1998-09-18 | 2006-11-28 | Lek Pharmaceuticals D.D. | Process for obtaining HMG-CoA reductase inhibitors of high purity |
| US6682913B1 (en) * | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
| JP3881240B2 (ja) * | 1999-11-30 | 2007-02-14 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | 醗酵ブロスからスタチン化合物を回収するための方法 |
| SK8312002A3 (en) * | 1999-12-14 | 2003-05-02 | Biogal Gyogyszergyar | Novel forms of pravastatin sodium |
| CN1468098A (zh) * | 2000-10-05 | 2004-01-14 | �ݰ¸Ƕ�ҩ������˾ | 基本上无普伐他汀内酯和表普伐他汀的普伐他汀钠和包含普伐他汀钠的组合物 |
| US20050215636A1 (en) * | 2000-10-05 | 2005-09-29 | Vilmos Keri | Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same |
| JP2002121172A (ja) * | 2000-10-16 | 2002-04-23 | Sankyo Co Ltd | プラバスタチン又はその薬理上許容される塩の精製方法 |
| DE10119718A1 (de) * | 2001-04-21 | 2002-10-31 | Boehringer Ingelheim Pharma | Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff |
| JP2003026634A (ja) * | 2001-07-17 | 2003-01-29 | Mercian Corp | プラバスタチンナトリウム塩の製造方法 |
| US6716615B2 (en) | 2002-02-27 | 2004-04-06 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Strains of saccharaothrix, process for producing pravastatin using the strains and isolation process of (HMG)-CoA reductase |
| JP3422791B2 (ja) | 2002-08-06 | 2003-06-30 | 三共株式会社 | プラバスタチンの単離・精製方法 |
| KR100540761B1 (ko) * | 2002-08-09 | 2006-01-16 | 코바이오텍 (주) | 프라바스타틴 나트륨의 제조방법 |
| EP1477471A1 (en) * | 2003-05-14 | 2004-11-17 | Chunghwa Chemical Synthesis & Biotech Co., Ltd. | Process for purifying pravastin sodium from a fermentation broth |
| CA2546377A1 (en) * | 2003-11-24 | 2005-06-09 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Method of purifying pravastatin |
| RU2317991C1 (ru) * | 2003-12-05 | 2008-02-27 | Байокон Лимитид | Способ выделения и очистки макролидов |
| WO2006046130A2 (en) * | 2004-10-29 | 2006-05-04 | Ranbaxy Laboratories Limited | Process for the preparation of pravastatin |
| TW200640854A (en) * | 2005-02-09 | 2006-12-01 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Methods of making pravastatin sodium |
| JP4813841B2 (ja) * | 2005-07-25 | 2011-11-09 | キユーピー株式会社 | プラバスタチンナトリウムの製造方法 |
| DE102006028817A1 (de) * | 2006-06-21 | 2007-12-27 | Evonik Degussa Gmbh | Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen |
| WO2009078033A2 (en) * | 2007-12-18 | 2009-06-25 | Themis Medicare Limited | Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth |
| US20110130450A1 (en) * | 2008-04-02 | 2011-06-02 | Aad Johannes Bouman | Pravastatin extraction |
| IN2009MU00380A (https=) * | 2009-02-18 | 2010-04-02 | ||
| CN102993145B (zh) * | 2011-09-19 | 2015-06-03 | 北大方正集团有限公司 | 一种提取纯化洛伐他汀的方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4319039A (en) * | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
| MX7065E (es) * | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| DE3682557D1 (de) * | 1985-09-13 | 1992-01-02 | Sankyo Co | Hydroxy-ml-236b-derivate, deren herstellung und anwendung. |
| US4857547A (en) * | 1988-01-07 | 1989-08-15 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
| US4857522A (en) * | 1988-03-21 | 1989-08-15 | E. R. Squibb & Sons, Inc. | Derivatives of pravastatin for inhibiting cholesterol biosynthesis |
| US5180589A (en) * | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
| US5099035A (en) * | 1989-02-27 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| US5140012A (en) * | 1990-05-31 | 1992-08-18 | E. R. Squibb & Sons, Inc. | Method for preventing onset of restenosis after angioplasty employing pravastatin |
| US5202029A (en) | 1991-03-13 | 1993-04-13 | Caron Kabushiki Kaisha | Process for purification of hmg-coa reductase inhibitors |
| US5157025A (en) * | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
| NZ250609A (en) * | 1992-12-28 | 1995-07-26 | Sankyo Co | Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments |
| SI9300303A (en) | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
| US5616595A (en) | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Process for recovering water insoluble compounds from a fermentation broth |
| US5942423A (en) | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
| US5883109A (en) * | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
| WO1998037220A1 (en) * | 1997-02-20 | 1998-08-27 | Dsm N.V. | Nitrogen feed in statin fermentation |
| AU9264598A (en) | 1997-08-22 | 1999-03-16 | Gist-Brocades B.V. | Statin production by fermentation |
| SI9800046A (sl) * | 1998-02-18 | 1999-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti |
| SI20072A (sl) * | 1998-09-18 | 2000-04-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze |
| SK10932001A3 (sk) * | 1999-02-03 | 2002-06-04 | Institute For Drug Research Ltd. | Mikrobiálny spôsob výroby pravastatínu |
| US6682913B1 (en) * | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
| HUP9902352A1 (hu) | 1999-07-12 | 2000-09-28 | Gyógyszerkutató Intézet Kft. | Eljárás pravasztatin mikrobiológiai előállítására |
| JP3881240B2 (ja) * | 1999-11-30 | 2007-02-14 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | 醗酵ブロスからスタチン化合物を回収するための方法 |
| CN1468098A (zh) * | 2000-10-05 | 2004-01-14 | �ݰ¸Ƕ�ҩ������˾ | 基本上无普伐他汀内酯和表普伐他汀的普伐他汀钠和包含普伐他汀钠的组合物 |
-
2000
- 2000-11-28 JP JP2001541501A patent/JP3881240B2/ja not_active Expired - Fee Related
- 2000-11-28 CN CN00818725A patent/CN1433305A/zh active Pending
- 2000-11-28 WO PCT/US2000/032391 patent/WO2001039768A1/en not_active Ceased
- 2000-11-28 KR KR1020027006920A patent/KR20030026920A/ko not_active Abandoned
- 2000-11-28 CN CNA2005100739122A patent/CN1754872A/zh active Pending
- 2000-11-28 CA CA002393057A patent/CA2393057C/en not_active Expired - Fee Related
- 2000-11-28 HR HR20020454A patent/HRP20020454A2/xx not_active Application Discontinuation
- 2000-11-28 DE DE04010770T patent/DE04010770T1/de active Pending
- 2000-11-28 RU RU2002114072/13A patent/RU2002114072A/ru not_active Application Discontinuation
- 2000-11-28 AT AT00980834T patent/ATE342717T1/de not_active IP Right Cessation
- 2000-11-28 EP EP00980834A patent/EP1265604B1/en not_active Expired - Lifetime
- 2000-11-28 US US09/723,711 patent/US6444452B1/en not_active Expired - Fee Related
- 2000-11-28 PT PT00980834T patent/PT1265604E/pt unknown
- 2000-11-28 ES ES04010770T patent/ES2239937T1/es active Pending
- 2000-11-28 AT AT04010770T patent/ATE382344T1/de not_active IP Right Cessation
- 2000-11-28 YU YU39102A patent/YU39102A/sh unknown
- 2000-11-28 MX MXPA02005283A patent/MXPA02005283A/es unknown
- 2000-11-28 HU HU0204012A patent/HUP0204012A3/hu unknown
- 2000-11-28 DE DE60037687T patent/DE60037687D1/de not_active Expired - Lifetime
- 2000-11-28 PL PL00364918A patent/PL364918A1/xx unknown
- 2000-11-28 SK SK734-2002A patent/SK7342002A3/sk unknown
- 2000-11-28 DE DE60031447T patent/DE60031447T2/de not_active Expired - Fee Related
- 2000-11-28 AU AU18046/01A patent/AU1804601A/en not_active Abandoned
- 2000-11-28 ES ES00980834T patent/ES2273737T3/es not_active Expired - Lifetime
- 2000-11-28 DK DK00980834T patent/DK1265604T3/da active
-
2002
- 2002-05-16 ZA ZA200203912A patent/ZA200203912B/en unknown
- 2002-07-23 US US10/200,149 patent/US6689590B2/en not_active Expired - Fee Related
-
2003
- 2003-11-05 US US10/700,567 patent/US20040115781A1/en not_active Abandoned
-
2004
- 2004-07-13 JP JP2004206262A patent/JP2004350687A/ja active Pending
-
2005
- 2005-10-19 JP JP2005304900A patent/JP2006055174A/ja not_active Withdrawn
-
2006
- 2006-05-22 JP JP2006141646A patent/JP2006273861A/ja active Pending
-
2007
- 2007-01-15 CY CY20071100052T patent/CY1105925T1/el unknown
-
2008
- 2008-02-06 JP JP2008026632A patent/JP4343987B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2239937T1 (es) | Procedimiento para la recuperacion de compuestos de estanina a partir de un caldo de fermentacion. | |
| PL1659109T3 (pl) | Sposób wytwarzania wysokostężonych, zdolnych do płynięcia, wodnych roztworów betain | |
| AR018386A1 (es) | Método para preparar una composicion colectora de minerales. | |
| NZ553127A (en) | L-lactic, saccharin, cinnamic, salicyclic, benzenesulphonic and naphthalene-1,5-disulphonic acid addition salts of lercanidipine | |
| SE0103046L (sv) | Kristallin bas av citalopram | |
| CZ283540B6 (cs) | Způsob isolace lovastatinu | |
| EG25480A (en) | Method for preparation of optionally 2-substituted1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids | |
| UY24612A1 (es) | 5-(2-etoxi-5-(4-metilpiperazin-1-il-sulfonil)-fenil)-1-metil-3-n-propil-1,6-dihidro-7h-pirazol(4,3-d)pirimidin-7-ona | |
| CL2009000089A1 (es) | Procesos de preparacion de un derivado del acido y-amino-o-bifenil-x-metil-pentanoico;compuestos intermediarios y su proceso de preparacion; uso de los compuestos en la sintesis de compuestos inhibidores de nep, utiles en enfermedades cardiovasculares, tales como hipertension, insuficiencia cardiaca congestiva, entre otras. | |
| EA200101077A1 (ru) | Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его | |
| JP2003515334A5 (https=) | ||
| TW200501881A (en) | Composition for bactericide production and process for producing organic peracid | |
| JP2004510817A5 (https=) | ||
| Robins et al. | Biosynthesis of hyoscyamine involves an intramolecular rearrangement of littorine | |
| RU2003110580A (ru) | Способ очистки правастатина | |
| WO2009014105A1 (ja) | 新規カルボン酸およびそれを有効成分とする抗うつ用組成物 | |
| EP1327626A4 (en) | PRAVASTATIN PURIFICATION PROCESS | |
| AR037005A1 (es) | Derivados de acidos dimetilfenilaceticos, derivados de piperidina, y proceso para la produccion de derivados de piperidina. | |
| ATE373667T1 (de) | Verfahren zur herstellung von ceftiofur | |
| RU2010141977A (ru) | Циклическое соединение и его соль | |
| CA2420847A1 (en) | Process for producing erythromycin derivative | |
| AR029893A1 (es) | Metodo para la preparacion de citalopram, intermediarios y composicion farmaceutica | |
| RU2007122353A (ru) | Способ получения гидробромида галантамина | |
| ATE272643T1 (de) | Verfahren zur herstellung eines reinen, pharmacopoiealgrad amorphes form von cefuroxim axetil | |
| ES2232609T3 (es) | Procedimiento para la preparacion de derivados de 9-deoxo-8a-aza-(8a-alquil)-8a-homoeritromicina a a partir de la 9-deoxo-9 (z)-hidroxiiminoeritromicina a. |